190 matches for your search in the start-up spotlight
rssFounded in 2015 as a spin-out from Newcastle University. Newcells Biotech builds in vitro models and services to de-risk and improve clinical translation and drug discovery.
At Affinite, we understand the challenges that scientists face when working with techniques such as ELISA. That’s where our next-generation SPR devices become the solution. With Lensless SPR, you can optimize and validate your surface chemistry preparations in real-time, saving you hours of ...
Blue Whale Materials’ proprietary technology recycles spent lithium-ion batteries to safely reclaim and responsibly supply a high value Blacksand™ product that contains cobalt, nickel, and lithium for the growing electrified economy.
Our Vision: We at Calyxia believe that high-performance and eco-engineered chemical solutions are essential to fight pollution, protect biodiversity, and improve the quality of life for all. Our Mission: To build an advanced and sustainable future for the chemical industry by providing leading ...
BioBTX is a circular chemistry technology developer that makes it possible to replaces fossil resources for biomass & plastic waste. We use these renewable resources for the production of drop-in chemicals and aromatics to enable the production of sustainable and future proof materials. BioBTX ...
Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for ...
NORDTREAT is a Finnish technology company founded in 2015, specializing in the development and production of environmentally friendly, high-performance flame retardants. Utilizing bio-based raw materials, NORDTREAT's products comply with the latest fire protection regulations and have been used ...
Maxterial is a Bay Area technology company dedicated to pioneering advancements in material science, including the commercialization of advanced coatings. Founded in 2015, Maxterial leverages an eco-systemic lean tech approach to develop innovative solutions that protect against wear, heat, and ...
MIP Discovery designs and develops non-biological affinity reagents to accelerate the development and production of cell and gene therapies. Taking the industry beyond the limitations of biological reagents, these synthetic antibody alternatives enable greater insight and control over viral ...
Metrion Biosciences is a UK-based Contract Research Organization specialising in high quality ion channel screening and drug development expertise. We aim to provide our customers with access to a range of in vitro screening services that includes cardiac safety (hERG, CiPA panel of human cardiac ...